From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Still liking Essentra into 2022

By Chris Bailey of Financial Orbit | Friday 7 January 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I see that Aston Martin Lagonda (AML) observed this morning that its “year-end cash balance of c.£420 million, higher than previously anticipated…”.  That is no disaster for the car company but given its lack of conventional profitability, there will still be a lot to appraise at their formal numbers on the 24th February.  The shares might be up 3% today but they are still down by more than 25% during the last year.  Even though Formula 1 fans might regard the company as offering a lot of sales growth potential, personally I am not excited, even if it claims their DBX brand achieved ‘about 20% share of the luxury SUV market’.  A company owned by the rich, for the rich is never the easiest holding, especially as it has gone bust a number of times before historically.  It remains a clear avoid for me. 

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Gold

Sprott bullish on gold

 

SOS

Sosandar: when is the warning?

 

SCGL

Evil Banksta: TW schoolboy error

 

ARB

Worthless Argo what news Helios?

Sunday »

Bearcast

Tom Winnifrith Bearcast: macrobabble calls

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 13:23:02